Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank57
3Y CAGR+52.4%
5Y CAGR+7.7%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+52.4%/yr
Annual compound
5Y CAGR
+7.7%/yr
Recent acceleration
Percentile
P57
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 27.53% |
| 2024 | 109.85% |
| 2023 | -477.66% |
| 2022 | 7.78% |
| 2021 | 62.49% |
| 2020 | 18.99% |
| 2019 | 150.28% |
| 2018 | -208.71% |
| 2017 | -49.19% |
| 2016 | 49.19% |